AGREEMENTAgreement • March 31st, 1997 • Immulogic Pharmaceutical Corp /De • Pharmaceutical preparations • Missouri
1 EXHIBIT 10.35 CONSULTATION AGREEMENT This Consultation Agreement, dated as of January 1, 1992, between ImmuLogic Pharmaceutical Corporation, a Delaware corporation ("ImmuLogic"), and C. Garrison Fathman ("Consultant"). W I T N E S S E T H: WHEREAS,...Consultation Agreement • March 31st, 1997 • Immulogic Pharmaceutical Corp /De • Pharmaceutical preparations • Massachusetts
1 EXHIBIT 10.34 AMENDMENT NO. 1 TO RIGHTS AGREEMENT Amendment, dated as of April 3, 1996 (the "Amendment"), to RIGHTS AGREEMENT, dated as of July 11, 1995 (the "Agreement"), between ImmuLogic Pharmaceutical Corporation, a Delaware corporation (the...Rights Agreement • March 31st, 1997 • Immulogic Pharmaceutical Corp /De • Pharmaceutical preparations
2- 2 and Non-Qualified Stock Option Agreement dated 9/27/93 (the "First Option Agreement"); (b) a Stock Option to purchase 30,000 shares of Common Stock of the Company (the "Second Option") pursuant to a Non-Qualified Stock Option Agreement dated...Severance and Settlement Agreement and Release • March 31st, 1997 • Immulogic Pharmaceutical Corp /De • Pharmaceutical preparations • Massachusetts
1 EXHIBIT 10.32 SEVERANCE AND SETTLEMENT AGREEMENT ---------------------------------- AGREEMENT made as of the 5th day of March, 1997, by and between Immulogic Pharmaceutical Corporation (the "Company") and Malcolm L. Gefter, Ph.D. ("Dr. Gefter")....Severance and Settlement Agreement • March 31st, 1997 • Immulogic Pharmaceutical Corp /De • Pharmaceutical preparations • Massachusetts
1 EXHIBIT 10.38 December 8, 1995 Dr. C. Garrison Fathman Divison of Immunology & Rheumatology Room S-021 Stanford University School of Medicine Stanford, CA 94035-5111 Re: Consultation Agreement between ImmuLogic Pharmaceutical Corporation and Dr. C....Immulogic Pharmaceutical Corp /De • March 31st, 1997 • Pharmaceutical preparations
